Michael Scolaro

Michael Scolaro

Sep 19, 2017

Group 6 Copy 146
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Can cockroaches help us cure tularemia?

    Tularemia is a deadly disease caused by the bacterium Francisella tularensis (Ft). This bacterium is also a...

    Investigating the epidemiology of elephant endotheliotropic herpesvirus in Myanmar

    Elephant endotheliotropic herpesvirus hemorrhagic disease (EEHV-HD) is the leading cause of death of young Asian...

    Circulating biomarkers of fibrosis in captive gorillas: a pilot study

    Heart disease is the leading cause of death for gorillas in captivity. The ultimate goal of this project is...

    Backer Badge Funded